Biotech

All Articles

Lykos are going to ask FDA to reevaluate its own choice complying with rejection of MDMA therapy for post-traumatic stress disorder

.Following a bad presenting for Lykos Therapeutics' MDMA candidate for post-traumatic stress disorde...

AN 2 one-halfs head count, ceases period 3 trial after information disappoint

.AN2 Therapies is actually re-thinking its organization in feedback to lackluster midphase records, ...

Merck spends $700M for bispecific, snooping autoimmune position and also opportunity to test Amgen in cancer cells

.Merck &amp Co. is actually paying out $700 thousand ahead of time to test Amgen in a blood cancer m...

Gilead pays out J&ampJ $320M to go out licensing package for seladelpar

.Along With Gilead Sciences about to an FDA choice for its liver health condition medication seladel...

' All palms on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks may find the firms establishing tents at basecamp behind Eli Li...

Entero giving up staff, moving out of office as well as stopping R&ampD

.Mattress Liquidators has actually transformed Entero Therapies white as a piece. The collector got ...

Exelixis falls ADC after choosing it is actually no suit for Tivdak

.Exelixis is surrendering on its tissue factor (TF)- targeting antibody-drug conjugate after wrappin...

Relay dislikes SHP2 prevention after Genentech leaves behind

.Three full weeks after Roche's Genentech system ignored an SHP2 prevention treaty, Relay Rehab has ...

Stoke's Dravet disorder med released of partial medical grip

.Stoke Therapies' Dravet disorder medication has been devoid of a predisposed grip, removing the tec...

Fierce Biotech's Gabrielle Masson provides Fierce 15 at NYSE

.Tough Biotech Partner Editor Gabrielle Masson showed the 2024 course of Ferocious 15 winners on the...